Fundraising Fox

Florian Muellershausen

Investor

Managing Director at Novartis Venture Fund

Basel, Switzerland

Find your path to Florian

172 people in our graph share verified history with Florian — schools, employers, funds. One of them is your warm intro.

Steffen WagnerunlockedFlorian: together at Freie Universität Berlin (1994–1996)
×10Florian: together at Freie Universität Berlin
Florian: together at Novartis Venture Fund

About

Florian Muellershausen, PhD, is a Managing Director at the Novartis Venture Fund based in Basel, Switzerland. Before joining the fund, he served as a Scientific Manager for the R&D Committee of the Novartis Board of Directors and held drug discovery roles in Novartis R&D, including Laboratory Head in target discovery and Translational Medicine Expert in autoimmunity. He holds an MSc in Biochemistry from Free University Berlin, a PhD in Biochemistry from Ruhr University Bochum, and completed postdoctoral training at Novartis in Switzerland.

Invests in

Biotech

Experience

  1. Novartis Venture FundManaging Directorcurrent2019 — presentBasel Metropolitan Area
  2. Novartis Venture FundPrincipal2017 — 2019Basel, Basel, Switzerland
  3. NovartisScientific Manager, Board Office2015 — 2017Basel, Basel, Switzerland
  4. NovartisTranslational Medicine Expert - Senior Investigator II - Autoimmunity2014 — 2015Basel, Basel, Switzerland
  5. NovartisTranslational Medicine Expert - Senior Investigator I, Autoimmunity2011 — 2014Basel, Basel, Switzerland
  6. NovartisProject Team Head - Investigator III, Translational Medicine Associate Autoimmunity2010 — 2011
  7. NovartisLaboratory Head - Investigator II2007 — 2010
  8. NovartisPostdoc2005 — 2007
  9. Ruhr-Universität Bochum, Institute for PharmacologyPostdoc2003 — 2004

Skills & more

Clinical Development23Translational Medicine27Signal Transduction13Molecular PharmacologyDrug Discovery32Pharmacology6Clinical Trials15PharmaceuticalsCell Biology10Genomics4Biomarker Discovery7Target Identification4
+6 moreBiomarkersClinical ResearchLife SciencesDrug discoveryDrug DevelopmentPharmaceutical Industry

From Florian's professional profile.

Investments

Board seats

AnaveonCitryllLoQus23 TherapeuticsONL TherapeuticsRhyGazeSalvinaSpliceBio

Investor

Amphista TherapeuticsAnaveonArtios PharmaCitryllFoRx TherapeuticsLOQUS23 THERAPEUTICSNRG TherapeuticsRhyGaze AG

Sources: the firm's website · curated public sources.

Colleagues at Novartis Venture Fund

Network5

Investors connected to Florian in public investor directories — a warm-intro map.

Frequently asked questions

Who is Florian Muellershausen?
Florian Muellershausen, PhD, is a Managing Director at the Novartis Venture Fund based in Basel, Switzerland. Before joining the fund, he served as a Scientific Manager for the R&D Committee of the Novartis Board of Directors and held drug discovery roles in Novartis R&D, including Laboratory Head in target discovery and Translational Medicine Expert in autoimmunity. He holds an MSc in Biochemistry from Free University Berlin, a PhD in Biochemistry from Ruhr University Bochum, and completed postdoctoral training at Novartis in Switzerland.
Where does Florian Muellershausen work?
Florian Muellershausen is Managing Director at Novartis Venture Fund.
What does Florian Muellershausen invest in?
Florian Muellershausen invests in Biotech.
What boards does Florian Muellershausen sit on?
Florian Muellershausen holds tracked board seats at Anaveon, Citryll, LoQus23 Therapeutics, ONL Therapeutics, RhyGaze, Salvina, SpliceBio.
What companies has Florian Muellershausen invested in?
Investments tracked here include Amphista Therapeutics, Anaveon, Artios Pharma, Citryll, FoRx Therapeutics, LOQUS23 THERAPEUTICS, NRG Therapeutics, RhyGaze AG.
Where did Florian Muellershausen go to school?
Florian Muellershausen studied at Ruhr University Bochum (Dr. rer. nat. (PhD), Molecular Pharmacology); Freie Universität Berlin (Diploma (eq. to MSc, Biochemistry).

Same school

Shared employers